PET Radiopharmacy

The true potential of PET is its ability to enable a true discovery. A true discovery is different, because it provides reproducible evidence that reveals a greater truth about the human body. A truth that has the ability to not only change the life of one patient, but to transcend an individual to benefit all patients.

Everything we do is with the purpose of providing you with the tools you need to go in search of true discovery.

For PET, it requires a commitment to making PET tracer production both accessible and reliable. With this as our focus for over 30 years, we have developed a wide array of ever-evolving PET tracer production technologies and the only complete PET solution in the industry. All designed to help you get your PET department up and running right away.

TRUE DISCOVERY AWAITS

LEARN HOW WE'RE ENABLING TRUE DISCOVERY WITH PET RADIOPHARMACY
PET MIP image depicting extensive
[68Ga]Ga-DOTA-TATE uptake in the liver.
PET MIP image depicting extensive
[68Ga]Ga-DOTA-TATE uptake in the liver.

There has never been a better time to explore the clinical potential of 68Ga. This nuclide has shown incredible promise, but its use has been limited because its production requires a more costly generator that is difficult to acquire. With our PET tracer production technologies, that’s no longer the case. Our PETtrace™ 800 Series of cyclotrons include 68Ga production capability. This means you don’t have to rely on an in-house generator to produce this short-lived radioisotope. You can use your cyclotron, which is a much more cost effective and efficient solution. And now, you can purify and label it using a single cassette on our FASTlab™ Developer automated chemistry platform. Together, these PET tracer production technologies open up a whole new avenue to pursue true discovery with 68Ga labelled compounds.